Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy comparison of two botulinum toxin type A products in cervical dystonia
2005-006169-15Phase 4Terminated
- Sponsor
- Allergan
- Start
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in cervical dystonia (CD) (2 arms), sponsored by Allergan. Primary endpoint: Change in TWSTRS score at 4 weeks. Started Feb 2007; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on 2005-006169-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006169-15.